NLRP3 and early-onset autosomal dominant Alzheimer disease: Previous research has found conflicting evidence linking the NLRP3 and IL-1 polymorphisms to a variety of inflammatory diseases, including inflammatory bowel disease, n increased severity of rheumatoid arthritis, an increased risk of Alzheimer’s disease, and other inflammatory diseases [18].